204 related articles for article (PubMed ID: 24161361)
1. Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Bienvenu B; Ruivard M; Terrier B; Pagnoux C; Mouthon L; Guillevin L;
Autoimmun Rev; 2014 Feb; 13(2):197-205. PubMed ID: 24161361
[TBL] [Abstract][Full Text] [Related]
2. Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.
Samson M; Puéchal X; Mouthon L; Devilliers H; Cohen P; Bienvenu B; Ly KH; Bruet A; Gilson B; Ruivard M; Pertuiset E; Hamidou M; Pagnoux C; Terrier B; Guillevin L;
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):176-184. PubMed ID: 28422001
[TBL] [Abstract][Full Text] [Related]
3. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Bienvenu B; Terrier B; Pagnoux C; Mouthon L; Guillevin L;
Autoimmun Rev; 2014 Sep; 13(9):945-53. PubMed ID: 25153486
[TBL] [Abstract][Full Text] [Related]
4. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
[TBL] [Abstract][Full Text] [Related]
5. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
6. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
[TBL] [Abstract][Full Text] [Related]
7. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.
Guillevin L; Cohen P; Mahr A; Arène JP; Mouthon L; Puéchal X; Pertuiset E; Gilson B; Hamidou M; Lanoux P; Bruet A; Ruivard M; Vanhille P; Cordier JF
Arthritis Rheum; 2003 Feb; 49(1):93-100. PubMed ID: 12579599
[TBL] [Abstract][Full Text] [Related]
8. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
Pagnoux C; Seror R; Henegar C; Mahr A; Cohen P; Le Guern V; Bienvenu B; Mouthon L; Guillevin L;
Arthritis Rheum; 2010 Feb; 62(2):616-26. PubMed ID: 20112401
[TBL] [Abstract][Full Text] [Related]
10. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?
Agard C; Mouthon L; Mahr A; Guillevin L
Arthritis Rheum; 2003 Oct; 49(5):709-15. PubMed ID: 14558058
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Stern M; Pagnoux C; Mouthon L; Guillevin L;
J Autoimmun; 2013 Jun; 43():60-9. PubMed ID: 23590801
[TBL] [Abstract][Full Text] [Related]
14. Classical polyarteritis nodosa and microscopic polyangiitis--a clinicopathologic study.
Handa R; Wali JP; Gupta SD; Dinda AK; Aggarwal P; Wig N; Biswas A
J Assoc Physicians India; 2001 Mar; 49():314-9. PubMed ID: 11291968
[TBL] [Abstract][Full Text] [Related]
15. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.
Bourgarit A; Toumelin PL; Pagnoux C; Cohen P; Mahr A; Guern VL; Mouthon L; Guillevin L;
Medicine (Baltimore); 2005 Sep; 84(5):323-330. PubMed ID: 16148732
[TBL] [Abstract][Full Text] [Related]
16. Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis.
Jung M; Barra L
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):129-134. PubMed ID: 29799394
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in Chinese patients.
Chen Y; Gao E; Yang L; Liu X; Li K; Liu Z; Zeng C; Zhang H; Liu Z; Hu W
Rheumatol Int; 2016 Jul; 36(7):967-74. PubMed ID: 27169414
[TBL] [Abstract][Full Text] [Related]
18. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
Puéchal X; Pagnoux C; Baron G; Lifermann F; Geffray L; Quémeneur T; Saraux JL; Wislez M; Cottin V; Ruivard M; Limal N; Aouba A; Bonnotte B; Néel A; Agard C; Cohen P; Terrier B; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Rheumatology (Oxford); 2019 Dec; 58(12):2107-2116. PubMed ID: 31056661
[TBL] [Abstract][Full Text] [Related]
19. Favourable renal survival in paediatric microscopic polyangiitis: efficacy of a novel treatment algorithm.
Basu B; Mahapatra TK; Mondal N
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i113-8. PubMed ID: 25758433
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
Puéchal X; Pagnoux C; Perrodeau É; Hamidou M; Boffa JJ; Kyndt X; Lifermann F; Papo T; Merrien D; Smail A; Delaval P; Hanrotel-Saliou C; Imbert B; Khouatra C; Lambert M; Leské C; Ly KH; Pertuiset E; Roblot P; Ruivard M; Subra JF; Viallard JF; Terrier B; Cohen P; Mouthon L; Le Jeunne C; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2016 Mar; 68(3):690-701. PubMed ID: 26473755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
